HYALURONIDASE RECOMBINANT HUMAN: 47 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
47
Total FAERS Reports
7 (14.9%)
Deaths Reported
44
Hospitalizations
47
As Primary/Secondary Suspect
8
Life-Threatening
3
Disabilities
Prescription
Status
FDA Application: 021859 ·
First Report: 20130705 · Latest Report: 20160417
What Are the Most Common HYALURONIDASE RECOMBINANT HUMAN Side Effects?
#1 Most Reported
Dehydration
7 reports (14.9%)
#2 Most Reported
Neutropenia
6 reports (12.8%)
#3 Most Reported
Sepsis
5 reports (10.6%)
All HYALURONIDASE RECOMBINANT HUMAN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Dehydration | 7 | 14.9% | 0 | 7 |
| Neutropenia | 6 | 12.8% | 0 | 5 |
| Atrial fibrillation | 5 | 10.6% | 0 | 5 |
| Sepsis | 5 | 10.6% | 1 | 5 |
Who Reports HYALURONIDASE RECOMBINANT HUMAN Side Effects? Age & Gender Data
Gender: 32.9% female, 67.1% male. Average age: 65.3 years. Most reports from: US. View detailed demographics →
Is HYALURONIDASE RECOMBINANT HUMAN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2013 | 11 | 1 | 11 |
| 2014 | 11 | 3 | 9 |
| 2015 | 13 | 2 | 13 |
| 2016 | 8 | 0 | 8 |
What Is HYALURONIDASE RECOMBINANT HUMAN Used For?
| Indication | Reports |
|---|---|
| Pancreatic carcinoma | 41 |
Official FDA Label for HYALURONIDASE RECOMBINANT HUMAN
Official prescribing information from the FDA-approved drug label.